{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T17:31:42Z","timestamp":1761154302396},"reference-count":15,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2001,9,1]],"date-time":"2001-09-01T00:00:00Z","timestamp":999302400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2001,12,20]]},"abstract":"<jats:title>Summary<\/jats:title>\n               <jats:p>The inflammatory response in infectious and autoimmune diseases is regulated by the balance between pro- and anti-inflammatory cytokines. The IL-1 complex contains polymorphic genes coding for IL-1\u03b1, IL-1\u03b2 and IL-1Ra. The IL-1Ra (variable number of tanden repeat) VNTR polymorphism has been shown to influence the capacity to produce IL-1\u03b2 and IL-1Ra after in vitro stimulation. Allele 2 of this polymorphism is associated with a number of inflammatory diseases. To determine the impact of the IL-1Ra polymorphism on in vivo human cytokine synthesis, we used a yellow fever vaccination model for the induction of cytokine synthesis in healthy volunteers. Two different yellow fever vaccines were used. After administration of the RKI vaccine (34 volunteers), plasma TNF-\u03b1 concentration increased from 13\u00b74\u2003\u00b1\u20030\u00b79\u2003pg\/ml to 23\u00b73\u2003\u00b1\u20031\u00b71\u2003pg\/ml (P\u2003&amp;lt;\u20030\u00b7001), and plasma IL-1Ra concentration increased from 308\u2003\u00b1\u200325\u2003pg\/ml to 1019\u2003\u00b1\u2003111\u2003pg\/ml (P\u2003&amp;lt;\u20030\u00b7001), on day 2. Using Stamaril\u00ae vaccine, no increase in the plasma concentrations of either TNF-\u03b1 or IL-1Ra could be detected (n\u2003=\u200317). Only the RKI vaccine induced TNF-\u03b1 synthesis after in vitro stimulation of MNC. Carriers of allele 2 of the IL-1Ra polymorphism had increased baseline concentrations of IL-1Ra (350\u2003\u00b1\u200332\u2003pg\/ml) compared with non-carriers (222\u2003\u00b1\u200318\u2003pg\/ml, P\u2003&amp;lt;\u20030\u00b7001), and decreased concentrations of IL-1\u03b2 (0\u00b79\u2003\u00b1\u20030\u00b72\u2003pg\/ml for carriers versus 2\u00b78\u2003\u00b1\u20030\u00b77\u2003pg\/ml for non-carriers, P\u2003=\u20030\u00b7017). After yellow fever vaccination (RKI vaccine), no significant differences in the increase of IL-1Ra plasma levels were detected between carriers and non-carriers of allele 2 of the IL-1Ra gene polymorphism. This is the first study to examine the influence of this genetic polymorphism on in vivo-induced human IL-1\u03b2 and IL-1Ra synthesis. Baseline concentrations of IL-1Ra and IL-1\u03b2 were significantly influenced by the IL-1Ra polymorphism. No influence of the IL-1Ra polymorphism on the in vivo-induced production of IL-1Ra and IL-1\u03b2 could be detected.<\/jats:p>","DOI":"10.1046\/j.1365-2249.2001.01621.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T10:28:40Z","timestamp":1047378520000},"page":"465-469","source":"Crossref","is-referenced-by-count":35,"title":["Influence of the IL-1Ra gene polymorphism on <i>in vivo<\/i> synthesis of IL-1Ra and IL-1\u03b2 after live yellow fever vaccination"],"prefix":"10.1093","volume":"125","author":[{"given":"U T","family":"Hacker","sequence":"first","affiliation":[{"name":"Division of Clinical Pharmacology, Germany"},{"name":"Medical Department III, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Erhardt","sequence":"additional","affiliation":[{"name":"Division of Clinical Pharmacology, Germany"},{"name":"Department of Anaesthesiology, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Tsch\u00f6p","sequence":"additional","affiliation":[{"name":"Division of Clinical Pharmacology, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T","family":"Jelinek","sequence":"additional","affiliation":[{"name":"Division of Tropical Medicine and Infectious Diseases, all University Hospital, Ludwig-Maximilians-University, Munich, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Endres","sequence":"additional","affiliation":[{"name":"Division of Clinical Pharmacology, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2001,12,20]]},"reference":[{"key":"2022011306424648000_b1","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1182\/blood.V87.6.2095.bloodjournal8762095","article-title":"Biologic basis for interleukin-1 in disease","volume":"87","author":"Dinarello","year":"1996","journal-title":"Blood"},{"key":"2022011306424648000_b2","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/BF00217368","article-title":"Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86-bp tandem repeat","volume":"91","author":"Tarlow","year":"1993","journal-title":"Hum Genet"},{"key":"2022011306424648000_b3","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/0016-5085(94)90696-3","article-title":"Novel genetic association between ulcerative colitis and the anti-inflammatory cytokine interleukin-1 receptor antagonist","volume":"106","author":"Mansfield","year":"1994","journal-title":"Gastroenterology"},{"key":"2022011306424648000_b4","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/S0016-5085(99)70338-0","article-title":"Functional and ethnic association of allele 2 of the interleukin-1 receptor antagonist gene in ulcerative colitis","volume":"117","author":"Tountas","year":"1999","journal-title":"Gastroenterology"},{"key":"2022011306424648000_b5","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/S0140-6736(95)91607-5","article-title":"Interleukin-1 receptor antagonist gene polymorphism and multiple sclerosis","volume":"346","author":"Crusius","year":"1995","journal-title":"Lancet"},{"key":"2022011306424648000_b6","first-page":"111","article-title":"Association of Graves' disease with an allele of the interleukin-1 receptor antagonist gene","volume":"80","author":"Blakemore","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"2022011306424648000_b7","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/s004390050055","article-title":"Interleukin-1 receptor antagonist allele (IL1RN*2) associated with nephropathy in diabetes mellitus","volume":"97","author":"Blakemore","year":"1996","journal-title":"Hum Genet"},{"key":"2022011306424648000_b8","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1136\/gut.41.5.651","article-title":"Imbalance of the interleukin 1 system in colonic mucosa \u2014 association with intestinal inflammation and interleukin 1 receptor antagonist genotype 2","volume":"41","author":"Andus","year":"1997","journal-title":"Gut"},{"key":"2022011306424648000_b9","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1365-2249.1995.tb05549.x","article-title":"Cytokine production by normal human monocytes: inter-subject variation and relationship to an IL-1 receptor antagonist (IL-1Ra) gene polymorphism","volume":"99","author":"Danis","year":"1995","journal-title":"Clin Exp Immunol"},{"key":"2022011306424648000_b10","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1046\/j.1365-3083.1998.00300.x","article-title":"Presence of the IL-1RA allele 2 (IL1RN*2) is associated with enhanced IL-1\u03b2 production in vitro","volume":"47","author":"Santtila","year":"1998","journal-title":"Scand J Immunol"},{"key":"2022011306424648000_b11","doi-asserted-by":"publisher","first-page":"2598","DOI":"10.1002\/(sici)1521-4141(199808)28:08&lt;2598::aid-immu2598&gt;3.3.co;2-b","article-title":"IL-1 receptor antagonist (IL-1Ra) plasma levels are co-ordinately regulated by both IL-1Ra and IL-1 \u03b2 genes","volume":"28","author":"Hurme","year":"1998","journal-title":"Eur J Immunol"},{"key":"2022011306424648000_b12","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1086\/517806","article-title":"In vivo synthesis of tumor necrosis factor-\u03b1 in healthy humans after live yellow fever vaccination","volume":"177","author":"Hacker","year":"1998","journal-title":"J Infect Dis"},{"key":"2022011306424648000_b13","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1097\/00003246-199907000-00024","article-title":"Comparison of two polymorphisms of the interleukin-1 gene family: interleukin-1 receptor antagonist polymorphism contributes to susceptibility to severe sepsis","volume":"27","author":"Fang","year":"1999","journal-title":"Crit Care Med"},{"key":"2022011306424648000_b14","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1038\/35006081","article-title":"Interleukin-1 polymorphisms associated with increased risk of gastric cancer","volume":"404","author":"El-Omar","year":"2000","journal-title":"Nature"},{"key":"2022011306424648000_b15","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.2337\/diab.43.10.1242","article-title":"Monokine antagonism is reduced in patients with IDDM","volume":"43","author":"Mandrup-Poulsen","year":"1994","journal-title":"Diabetes"}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2249.2001.01621.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2249.2001.01621.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/125\/3\/465\/42163284\/j.1365-2249.2001.01621.x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/125\/3\/465\/42163284\/j.1365-2249.2001.01621.x.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T11:50:36Z","timestamp":1676375436000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/125\/3\/465\/6461306"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,9]]},"references-count":15,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2001,12,20]]},"published-print":{"date-parts":[[2001,12,20]]}},"URL":"https:\/\/doi.org\/10.1046\/j.1365-2249.2001.01621.x","relation":{},"ISSN":["1365-2249","0009-9104"],"issn-type":[{"value":"1365-2249","type":"electronic"},{"value":"0009-9104","type":"print"}],"subject":[],"published-other":{"date-parts":[[2001,9]]},"published":{"date-parts":[[2001,9]]}}}